A sincere thank you to all of our sponsors, speakers and attendees from all of us on The MedTech Strategist team for attending Innovation Summit San Francisco! We sincerely hope that it was productive and enjoyable for you and your team! Your feedback is welcome and appreciated.
We hope to see you in Dublin this April!
THIS CONFERENCE HAS CONCLUDED
Is your early-stage medtech company looking to meet high-quality investors or strategic partners? Our Innovation Summit San Francisco 2017 stage is your ideal chance to shine.
Keep Up to Date on the Latest Conference Updates - Sign Up for Our E-mail Alerts
The MedTech Strategist, which has produced two of the world’s most successful events in recent years for investors and emerging medical device companies, with summits in Dublin, Ireland and San Francisco, as well as a well-respected publication providing essential, impactful device industry perspective and insight, is proud to announce "The MedTech Strategist Innovation Summit San Francisco 2017," formerly known as the Emerging Medical Technologies (EMT) Summit. The two-day event is taking place this November 28-29 at the Hyatt Regency San Francisco Airport, in the hub of medtech innovation and investment in California's Silicon Valley. See the event agenda here.
Innovation Summit San Francisco will be a top-tier forum for innovative emerging medical technology companies seeking investment, joint venture or other relationships to gain exposure to venture capital, investment bankers and large medical device companies for the purpose of potential investment and/or strategic partnership. It is organized as a two-day business partnering and networking event, featuring 40+ pre-screened start-up medical technology companies that will deliver 10-minute presentations, followed by meetings in private breakout rooms. The Summit will also feature thought-leading guest speakers, and plenary and panel sessions, all providing candid insight on topics of utmost importance to all stakeholders in the rapidly evolving global device marketplace.
In attendance will be 400+ of the top medical device VCs and senior business development executives from California's vibrant Silicon Valley area, as well as many other parts of the U.S., Europe, Asia and around the world, in addition to management teams from many of the most promising start-ups in the global device space.
Presentations by 40+ Hand-Selected Start-Up Medical Device Companies seeking investment and/or partnership, followed by breakout sessions
Special Guest Speaker: Howard Root, former CEO of Vascular Solutions (acquired by Teleflex for $1bn) and author of Cardiac Arrest: Five Heart-Stopping Years as a CEO on the Feds' Hit-List.
Corporate, Venture Capital, Asian Investment, and Entrepreneur Panel Discussions
Unparalleled access to top-tier global medtech VCs and entrepreneurs discussing their perspectives and investment strategies/experiences - hosted by The MedTech Strategist's Editors-in-Chief, David Cassak and Stephen Levin
JUJAMA Partnering App
Connect with other attendees before, during and after the conference, arrange meetings, message, interact on the private social media feed, upload videos and documents and much more.
Networking Breaks, Breakfasts, Lunches, Evening Cocktail Receptions, and Much More
The MedTech Strategist, an information and investment conferences provider focused exclusively on the under-served medtech market, is led by managing partners and co-editors-in-chief David Cassak and Stephen Levin, along with a seasoned editorial team and staff. The company launched The MedTech Strategist, a publication broadly covering the most important topics and trends in medical devices today, in September 2014. Featuring a wide range of editorial offerings — from interviews with industry leaders to stories on leading companies, profiles of ground-breaking start-ups and analyses of dynamic clinical markets and technology trends — The MedTech Strategist, in 18 issues per year (40-52 pages per issue), provides not only insight on trends that our seasoned team foresees in the global device space, in most cases months before it is announced in the general press, but also puts this in context for you as you assess your current portfolio and business challenges. We provide you and your team with essential global industry perspective, including insight and analysis that is currently sorely missing in the medtech industry.